ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 360 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $250 | -17.5% | 8,915 | -20.3% | 0.02% | -20.0% |
| Q3 2023 | $303 | -94.4% | 11,179 | -93.6% | 0.02% | -94.4% |
| Q2 2023 | $5,363 | +5.3% | 174,450 | +23.4% | 0.36% | -9.9% |
| Q1 2023 | $5,094 | -6.7% | 141,381 | +2.3% | 0.39% | -14.5% |
| Q4 2022 | $5,462 | -99.9% | 138,200 | +0.4% | 0.46% | -9.8% |
| Q3 2022 | $5,530,000 | -5.0% | 137,619 | -0.6% | 0.51% | -0.4% |
| Q2 2022 | $5,823,000 | +12.4% | 138,510 | +4.2% | 0.51% | +34.3% |
| Q1 2022 | $5,180,000 | – | 132,965 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |